Tafasitamab (Anti-CD19)
Tafasitamab (Anti-CD19) is an Fc-modified, humanized monoclonal antibody that binds to the human B-cell surface antigen CD19. It is used in combination with allogeneic NK cell therapy in treatment of B-cell non-Hodgkin’s lymphoma. MW:145.5 KD.
| Trivial name | XmAb5574; MOR00208; Tafasitamab-cxix |
| Catalog Number | A2563 |
| CAS# | 1422527-84-1 |
| Size | 1mg |
| Supplier Page | http://www.selleckchem.com/products/tafasitamab-anti-cd19.html |